Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma

A Cucchetti, F Piscaglia, M Cescon, A Colecchia… - Journal of …, 2013 - Elsevier
Background & Aims Both hepatic resection and radiofrequency ablation (RFA) are
considered curative treatments for hepatocellular carcinoma (HCC), but their economic
impact still remains not determined. Aim of the present study was to analyze the cost-
effectiveness (CE) of these two strategies in early stage HCC (Milan criteria). Methods As
first step, a meta-analysis of the pertinent literature of the last decade was performed.
Seventeen studies fulfilled the inclusion criteria: 3996 patients underwent resection and …
以上显示的是最相近的搜索结果。 查看全部搜索结果